Poultry farmers in the U.S. and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines to protect workers from the highly pathogenic avian influenza that is on the rise. The virus has spread to dairy cattle and poses a potential risk of mutation to spread easily in humans.
Key Points
Vaccines are being acquired to protect workers in close contact with infected animals
The virus has spread to dairy cattle in the U.S., raising concerns about wider transmission
Discussions are ongoing at government and scientific levels regarding the use of prepandemic vaccines
Pros
Efforts to acquire vaccines could protect at-risk poultry and dairy workers
Vaccines could curb the threat of a potential pandemic
Preventive measures are being discussed to avoid widespread infections in humans
Cons
Uncertainty about the necessity of deploying vaccines to curb the virus
Potential mutations in the virus could increase the risk of transmission to humans